{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T19:02:35Z","timestamp":1781290955830,"version":"3.54.1"},"reference-count":34,"publisher":"Informa UK Limited","issue":"8","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Santen SA. Ana Tadeu of OPEN Health Communications (London, UK) provided writing, editorial, and formatting support"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Ocular Immunology and Inflammation"],"published-print":{"date-parts":[[2023,9,14]]},"DOI":"10.1080\/09273948.2022.2088566","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T14:03:52Z","timestamp":1656511432000},"page":"1707-1715","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Ciclosporin A Cationic Emulsion 0.1% for the Management of Dry Eye Disease: Facts That Matter for Eye-Care Providers"],"prefix":"10.1080","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1680-1887","authenticated-orcid":false,"given":"Marc","family":"Labetoulle","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Paris-Sud University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7246-8580","authenticated-orcid":false,"given":"Andrea","family":"Leonardi","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Ophthalmology Unit, University of Padua, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9729-5444","authenticated-orcid":false,"given":"Pierre-Jean","family":"Pisella","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Bretonneau University Hospital, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1743-6698","authenticated-orcid":false,"given":"Christophe","family":"Baudouin","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Quinze-Vingts National Ophthalmology Hospital and Vision Institute, IHU FOReSIGHT, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.10.023"},{"key":"e_1_3_4_3_1","unstructured":"European Medicines Agency. Ikervis. European public assessment report 2015 updated 16\/06\/2021. Available at: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/ikervis."},{"key":"e_1_3_4_4_1","unstructured":"US FDA. Drug approval package. Restasis cyclosporine ophthalmic emulsion 2005. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2003\/21-023_Restasis.cfm."},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S115098"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2017.05.006"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2017.05.008"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21239271"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2013.07.003"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-307415"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0181-5512(07)89584-2"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2019.0060"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.07.010"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S184412"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.12.027"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2019.11.020"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S228838"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S226168"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-306930"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.12898"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.5301\/ejo.5001002"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.5301\/EJO.5000952"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2018.09.012"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.5301\/ejo.5000779"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2021.1957124"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2018.1479742"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0834-x"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02271"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2017-311801"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S279051"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2020.0146"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S150957"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-018-0289-7"},{"key":"e_1_3_4_34_1","doi-asserted-by":"crossref","unstructured":"Geerling G Hamada S Trocm\u00e9 S et al. Real-world effectiveness tolerability and safety of cyclosporine A 0.1% cationic emulsion in severe keratitis and dry eye treatment. Ophthalmol Ther . 2022;11(3):1101\u20131117.","DOI":"10.1007\/s40123-022-00487-x"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2020-317907"}],"container-title":["Ocular Immunology and Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09273948.2022.2088566","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T19:12:16Z","timestamp":1696360336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/09273948.2022.2088566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,9,14]]}},"alternative-id":["10.1080\/09273948.2022.2088566"],"URL":"https:\/\/doi.org\/10.1080\/09273948.2022.2088566","relation":{},"ISSN":["0927-3948","1744-5078"],"issn-type":[{"value":"0927-3948","type":"print"},{"value":"1744-5078","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ioii20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ioii20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-03-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}